REFERENCES
- Ambiavagar, P. C., & Sher, J. (1978). Subdural hematoma secondary to metastatic neoplasm: Report of two cases and a review of the literature. Cancer, 42(4), 2015–2018.
- Bendell, J. C., Domchek, S. M., Burstein, H. J., Harris, L.,Younger, J., Kuter, I., (2003).Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer, 97(12), 2972–2977.
- Bendszus, M., Warmuth-Metz, M., Burger, R., Klein, R., Tonn J. C., & Solymosi, L. (2001). Diagnosing dural metastases: The value of 1H magnetic resonance spectroscopy. Neuroradiology, 43(4), 285–289.
- Chang, L., & Lo, S. (2003). Diagnosis and management of central nervous system metastases from breast cancer. Oncologist, 8(5), 398–410.
- Cheng, Y. K., Wang, T. C., Yang, J. T., Lee, M. H., & Su, C. H. (2009). Dural metastasis from prostatic adenocarcinoma mimicking chronic subdural hematoma. Journal of Clinical Neuroscience, 16(8), 1084–1086.
- Clayton, A. J., Danson, S., Jolly, S., Ryder, W. D., Burt, P. A., Stewart, A. L., (2004). Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. British Journal of Cancer, 91(4), 639–643.
- DiStefano, A., Yong, Yap Y., Hortobagyi, G. N., & Blumenschein, G. R. (1979). The natural history of breast cancer patients with brain metastases. Cancer, 44(5), 1913–1918.
- Harputluoglu, H., Kara, A., Dizdar, O., Surmeli, Z. G., & Altundag, K. (2008). Prognostic factors in long-term breast cancer survivors with brain metastases. Breast Cancer Research and Treatment, 112(1), 215.
- Higashi, H., Fukutomi, T., Watanabe, T., Adachi, I., Narabayashi, M., Shibui, S., (2000). Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases. Breast Cancer, 7(2), 153–156.
- Kleinschmidt-DeMasters, B. K. (2001). Dural metastases. A retrospective surgical and autopsy series. Archives of Pathology and Laboratory Medicine, 125(7), 880–887.
- Kunii, N., Morita, A., Yoshikawa, G., & Kirino, T. (2005). Subdural hematoma associated with dural metastasis-case report. Neurologia Medico-Chirurgica (Tokyo), 45(10), 519–522.
- Laigle-Donadey, F., Taillibert, S., Mokhtari, K., Hildebrand, J., & Delattre, J. Y. (2005). Dural metastases. Journal of Neurooncology, 75(1), 57–61.
- Lee, S. S., Ahn, J. H., Kim, M. K, Sym, S. J., Gong, G., Ahn, S. D., (2008). Brain metastases in breast cancer: Prognostic factors and management. Breast Cancer Research and Treatment, 111(3), 523–530.
- Lentzsch, S., Reichardt, P., Weber, F., Budach, V., & Dorken, B. (1999). Brain metastases in breast cancer: Prognostic factors and management. European Journal of Cancer, 35(4), 580–585.
- Maroldi, R., Ambrosi, C., & Farina, D. (2005). Metastatic disease of the brain: Extra-axial metastases (skull, dura, leptomeningeal) and tumour spread. European Radiology, 15(3), 617–626.
- Meyer, P. C., & Reah, T. G. (1953). Secondary neoplasms of the central nervous system and meninges. British Journal of Cancer, 7(4), 438–448.
- Nayak, L., Abrey, L. E., & Iwamoto, F. M. (2009). Intracranial dural metastases. Cancer, 115(9), 1947–1953.
- Posner, J. B., & Chernik, N. L. (1978). Intracranial metastases from systemic cancer. Advances in Neurology, 19, 579–592.
- Rajendra, T., Ann, L. K., Thomas, J., Hong, A., & Chan, C. (2003). Results of surgical treatment for cerebral metastases. Journal of Clinical Neuroscience, 10(2), 190–194.
- Shmueli, E., Wigler, N., & Inbar, M. (2004). Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment. European Journal of Cancer, 40(3), 379–382.
- Sijens, P. E., Oudkerk, M., Bendszus, M., Warmuth-Metz, M., Burger R., Klein, R., (2002). Diagnosing dural metastases. Neuroradiology, 44(3), 275.
- Tham, Y. L., Sexton, K., Kramer, R., Hilsenbeck, S., & Elledge, R. (2006). Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer, 107(4), 696–704.
- Tsukada, Y., Fouad, A., Pickren, J. W., & Lane, W. W. (1983). Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer, 52(12), 2349–2354.
- Yonemori, K., Tsuta, K., Ono, M., Shimizu, C., Hirakawa, A., Hasegawa, T., (2010). Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer. Cancer, 116(2), 302–308.